Pular para o conteúdo principal
Ranking Invest

NVS - Novartis AG

Segmento: HealthcareNovartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and a clinical collaboration with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

Análise Ranking Invest

Valor de Mercado
$ 294.78 Bi
IVR
0.31Índice proprietário de comparação relativa: 0,31.
IVR2
0.17Leitura proprietária complementar: 17%.
MLL
0.17Leitura proprietária complementar: 17%.
Último Balanço Atualizado: 2T2025

O Ranking Invest utiliza metodologia proprietária baseada em dados financeiros públicos; fórmulas e valores intermediários são confidenciais.

Dados da Empresa

Patrimônio Líquido

$ 41.92 Bi

Dívida Líquida

$ 25.98 Bi

L4T

$ 9.62 Bi

MM4T

17.87%

Indicadores Básicos

ROE

22.94%

Índices de Previsibilidade

Receita Líquida

B0.04

Lucro

C0.37

Margem

C0.39

Índices de Tendência

Receita Líquida

D1.08

Lucro

D1.49

Margem

D1.41

Índices de Endividamento

DIV/PAT

0.62

DIV/L4T

2.70

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.